Average Co-Inventor Count = 8.48
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (21 from 3,923 patents)
21 patents:
1. 12122761 - 2-azaspiro[3.4]octane derivatives as M4 agonists
2. 11820778 - 2-azaspiro[3.4]octane derivatives as M4 agonists
3. 11548865 - 2-azaspiro[3.4]octane derivatives as M4 agonists
4. 11485742 - 2-azaspiro[3.4]octane derivatives as M4 agonists
5. 10975080 - Compounds and compositions for inhibiting the activity of SHP2
6. 10287266 - Compounds and compositions for inhibiting the activity of SHP2
7. 10112931 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
8. RE46942 - 4-piperidinyl compounds for use as tankyrase inhibitors
9. 9822092 - ArylSulfonamide-based matrix metalloprotease inhibitors
10. 9688672 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
11. 9434719 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
12. 9227982 - 4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors
13. 9181266 - 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors
14. 9163003 - 4-piperidinyl compounds for use as tankyrase inhibitors
15. 8975439 - Arylsulfonamide based matrix metalloprotease inhibitors